Susquehanna International Group’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Sell |
10,151
-10,992
| -52% | -$13K | ﹤0.01% | 6191 |
|
|
2025
Q1 | $45.7K | Buy |
+21,143
| New | +$45.7K | ﹤0.01% | 6032 |
|
|
2023
Q2 | – | Sell |
-38,326
| Closed | -$88.2K | – | 5719 |
|
|
2023
Q1 | $88.2K | Sell |
38,326
-19,069
| -33% | -$43.9K | ﹤0.01% | 5290 |
|
|
2022
Q4 | $100K | Buy |
57,395
+23,758
| +71% | +$41.6K | ﹤0.01% | 4949 |
|
|
2022
Q3 | $87K | Buy |
+33,637
| New | +$87K | ﹤0.01% | 5326 |
|
|
2022
Q2 | – | Sell |
-38,927
| Closed | -$315K | – | 5874 |
|
|
2022
Q1 | $315K | Sell |
38,927
-14,179
| -27% | -$115K | ﹤0.01% | 4294 |
|
|
2021
Q4 | $425K | Buy |
53,106
+29,895
| +129% | +$239K | ﹤0.01% | 4017 |
|
|
2021
Q3 | $276K | Buy |
+23,211
| New | +$276K | ﹤0.01% | 4373 |
|
|
2021
Q2 | – | Sell |
-2,740
| Closed | -$66K | – | 5365 |
|
|
2021
Q1 | $66K | Buy |
2,740
+1,411
| +106% | +$34K | ﹤0.01% | 5033 |
|
|
2020
Q4 | $39K | Sell |
1,329
-1,338
| -50% | -$39.3K | ﹤0.01% | 4641 |
|
|
2020
Q3 | $41K | Buy |
+2,667
| New | +$41K | ﹤0.01% | 4243 |
|
|
2020
Q2 | – | Sell |
-1,422
| Closed | -$29K | – | 4302 |
|
|
2020
Q1 | $29K | Buy |
+1,422
| New | +$29K | ﹤0.01% | 4290 |
|
|
2019
Q4 | – | Sell |
-2,240
| Closed | -$75K | – | 4071 |
|
|
2019
Q3 | $75K | Sell |
2,240
-282
| -11% | -$9.44K | ﹤0.01% | 4139 |
|
|
2019
Q2 | $81K | Buy |
+2,522
| New | +$81K | ﹤0.01% | 4198 |
|
|
2018
Q3 | – | Sell |
-1,019
| Closed | -$84K | – | 3466 |
|
|
2018
Q2 | $84K | Sell |
1,019
-13,049
| -93% | -$1.08M | ﹤0.01% | 3319 |
|
|
2018
Q1 | $587K | Buy |
14,068
+11,614
| +473% | +$485K | ﹤0.01% | 1951 |
|
|
2017
Q4 | $80K | Buy |
+2,454
| New | +$80K | ﹤0.01% | 3367 |
|
|
2017
Q3 | – | Sell |
-1,785
| Closed | -$19K | – | 3248 |
|
|
2017
Q2 | $19K | Buy |
+1,785
| New | +$19K | ﹤0.01% | 3408 |
|
|
2016
Q1 | – | Sell |
-1,351
| Closed | -$13K | – | 3886 |
|
|
2015
Q4 | $13K | Buy |
+1,351
| New | +$13K | ﹤0.01% | 4136 |
|